Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Tableting Lipid-based Formulations For Oral Drug Delivery: A Case Study With Silica Nanoparticle-lipid-mannitol Hybrid Microparticles.

K. Bremmell, A. Tan, Amanda Martin, C. Prestidge
Published 2013 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Silica-lipid-mannitol hybrid (SLMH) microparticles have been developed that were compressible into high quality tablets suitable for oral dosing and delivery of poorly soluble drugs. SLMH tablets enable high lipid-loading levels (>40%) and retain the immediate release, enhanced lipase digestion and drug solubilisation performance. Specifically, we report formulation optimisation of SLMH microparticles and tablets using coumarin 102 (log P = 4.09) as a model Biopharmaceutics Classification System class II drug. SLMH tablets were acceptable according to standard British Pharmacopoeia friability, hardness and disintegration tests; this is not the case for conventional dry emulsions. Furthermore, in vitro dissolution and pancreatic-lipase-induced lipolysis studies under simulated intestinal conditions have demonstrated enzymatic-digestion-mediated drug solubilisation. SLMH microparticles and tablets are suitable as liquid lipid containing solid dosage forms for enhancing and controlling oral absorption of poorly soluble drugs.
This paper references
10.1211/0022357021771896
Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products
L. Sek (2002)
10.1016/S0168-3659(02)00050-0
Microemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo study.
K. Kawakami (2002)
10.1002/JPS.2600521209
Effect of Certain Tablet Formulation Factors on Dissolution Rate of the Active Ingredient I11
G. Levy (1963)
10.1201/9780824741969.AXH
Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System
Michael Levin (2001)
10.1016/S0378-5173(98)00024-6
Formulation of a lyophilized dry emulsion tablet for the delivery of poorly soluble drugs
S. Corveleyn (1998)
10.1016/J.IJPHARM.2004.08.014
Process characteristics and compaction of spray-dried emulsions containing a drug dissolved in lipid.
T. Hansen (2004)
10.1002/anie.201200409
Hybrid nanomaterials that mimic the food effect: controlling enzymatic digestion for enhanced oral drug absorption.
A. Tan (2012)
10.1039/B800209F
Material properties for making fast dissolving tablets by a compression method
S. Jeong (2008)
10.1002/JPS.20039
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine.
C. H. Porter (2004)
10.1021/mp9002442
Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems.
A. Tan (2010)
10.1023/B:PHAM.0000016283.87709.a9
Drug Solubilization Behavior During in Vitro Digestion of Suspension Formulations of Poorly Water-Soluble Drugs in Triglyceride Lipids
A. Kaukonen (2004)
10.1021/JS960085V
Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
W. Charman (1997)
10.1248/BPB.27.1993
Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib.
N. Subramanian (2004)
10.1038/nrd2197
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
10.1016/J.ADDR.2007.10.014
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
C. H. Porter (2008)
10.3109/03639049209069307
Design of Redispersible Dry Emulsion as an Advanced Dosage Form of Oily Drug (Vitamin E Nicotinate) by Spray-Drying Technique.
Take'uchi (1992)
10.1016/J.IJPHARM.2007.03.020
A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
B. Boyd (2007)
10.1007/s11095-006-9054-x
Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats
A. Dahan (2006)
10.1016/J.FOODCHEM.2010.11.027
Factors affecting lipase digestibility of emulsified lipids using an in vitro digestion model: Proposal for a standardised pH-stat method
Y. Li (2011)
10.1016/j.ijpharm.2011.02.038
Silica-lipid hybrid microcapsules: influence of lipid and emulsifier type on in vitro performance.
Li Hui Lim (2011)
10.1016/j.ijpharm.2011.12.027
Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol.
Nasrin Ghouchi-Eskandar (2012)
10.1016/J.EJPS.2006.02.005
Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides.
M. Grove (2006)
10.1016/S0169-409X(96)00489-9
Influence of lipolysis on drug absorption from the gastro-intestinal tract
Karen J. MacGregor (1997)
10.1194/jlr.M600258-JLR200
Inhibition of lipase activities by basic polysaccharide Published, JLR Papers in Press, November 8, 2006.
T. Tsujita (2007)
10.3109/03639049809097269
Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
V. Naini (1998)
10.1007/s11095-011-0458-x
Silica-Lipid Hybrid (SLH) Versus Non-lipid Formulations for Optimising the Dose-Dependent Oral Absorption of Celecoxib
A. Tan (2011)
10.1016/j.jconrel.2008.10.014
Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
A. Tan (2009)
10.1016/j.jconrel.2005.10.002
A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
Ji-Yeon Hong (2006)
10.1016/S0928-0987(01)00182-8
A dynamic in vitro lipolysis model. II: Evaluation of the model.
N. H. Zangenberg (2001)
10.1021/mp900063t
Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
S. Simović (2009)
10.1016/J.EJPS.2007.05.114
In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
I. S. Ahmed (2007)
10.1023/B:PHAM.0000036914.22132.cc
Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation
C. H. Porter (2004)
10.1016/S0928-0987(01)00169-5
A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium.
N. H. Zangenberg (2001)
10.1016/J.IJPHARM.2005.02.038
Enzymatic characterization of lipid-based drug delivery systems.
H. Ljusberg-Wahren (2005)
10.1016/J.EJPB.2007.01.017
The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
A. Dahan (2007)
10.1016/S0378-5173(00)00595-0
Technical optimisation of redispersible dry emulsions.
K. L. Christensen (2001)
10.1002/JPS.2600660903
Effect of shear mixing on in vitro drug release of capsule formulations containing lubricants.
K. Murthy (1977)



This paper is referenced by
10.1016/j.ejpb.2014.06.003
Tablets of pre-liposomes govern in situ formation of liposomes: concept and potential of the novel drug delivery system.
Ž. Vanić (2014)
10.3390/pharmaceutics12070687
Porous Nanostructure, Lipid Composition, and Degree of Drug Supersaturation Modulate In Vitro Fenofibrate Solubilization in Silica-Lipid Hybrids
Ruba Almasri (2020)
10.1615/CRITREVTHERDRUGCARRIERSYST.2014008502
Recent advances in self-emulsifying drug delivery systems (SEDDS).
B. Singh (2014)
10.1021/ACSAMI.6B13599
Nanostructured Montmorillonite Clay for Controlling the Lipase-Mediated Digestion of Medium Chain Triglycerides.
Tahnee J. Dening (2016)
Using Hybrid Nanostructure to Improve the Performance of Oral Lipid Based Drug Delivery Systems
C. Prestidge (2013)
10.4018/978-1-5225-4781-5.CH004
Innovative Strategies for Lipid-Based Drug Delivery
N. Sharma (2018)
10.1016/j.ijpharm.2017.04.063
Montmorillonite-lipid hybrid carriers for ionizable and neutral poorly water-soluble drugs: Formulation, characterization and in vitro lipolysis studies.
Tahnee J. Dening (2017)
10.1007/s11095-013-1107-3
Transforming Lipid-Based Oral Drug Delivery Systems into Solid Dosage Forms: An Overview of Solid Carriers, Physicochemical Properties, and Biopharmaceutical Performance
A. Tan (2013)
10.1016/j.xphs.2018.09.016
Improving Correlations Between Drug Solubilization and In Vitro Lipolysis by Monitoring the Phase Partitioning of Lipolytic Species for Lipid-Based Formulations.
Tahnee J. Dening (2019)
10.26180/5DEA0300E177B
Oral lipid-based drug delivery: Inhibiting and eliminating digestion to improve absorption of poorly soluble drugs.
O. Feeney (2019)
10.2217/nnm.14.37
Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
Shasha Rao (2014)
10.4018/JNN.2018010101
Exploring Novel Strategies for Lipid-Based Drug Delivery
S. Kotta (2018)
10.1080/03639045.2018.1542709
Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges
K. Bremmell (2019)
10.1021/acs.langmuir.5b00043
Formation of monodisperse hierarchical lipid particles utilizing microfluidic droplets in a nonequilibrium state.
M. Mizuno (2015)
Toward Directing Cell Fate: Carbon Nanotubes As Modulators of Extracellular and Transporters of Intracellular Cues
Qingsu Cheng (2013)
10.2174/1567201811666140716122644
Impact of solidification on the performance of lipid-based colloidal carriers: oil-based versus self-emulsifying systems.
A. Alinaghi (2015)
10.1007/s13346-013-0172-9
First in man bioavailability and tolerability studies of a silica–lipid hybrid (Lipoceramic) formulation: a Phase I study with ibuprofen
A. Tan (2013)
10.1016/j.addr.2016.04.007
50years of oral lipid-based formulations: Provenance, progress and future perspectives.
O. Feeney (2016)
10.1016/J.POWTEC.2018.09.068
Spray-drying of konjac glucomannan to produce microparticles for an application as antitubercular drug carriers
F. Guerreiro (2019)
10.1016/j.ejps.2016.10.026
Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs
Rokhsana Yasmin (2017)
10.1016/j.jconrel.2014.05.013
Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
Shasha Rao (2014)
10.1021/am5038577
Controlling the enzymatic digestion of lipids using hybrid nanostructured materials.
A. Tan (2014)
10.1002/jps.23914
Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Rokhsana Yasmin (2014)
10.1124/jpet.118.254466
Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance
Hayley B Schultz (2019)
10.15171/apb.2015.055
Furosemide Loaded Silica-Lipid Hybrid Microparticles: Formulation Development, in vitro and ex vivo Evaluation.
Swapna Sambaraj (2015)
years of oral lipid-based formulations : Provenance , progress and future perspectives ☆
O. Feeney (2016)
10.1208/s12248-015-9864-z
Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs
Rokhsana Yasmin (2015)
10.3390/pharmaceutics11060275
Tripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular System
Ibrahim Elsayed (2019)
10.1021/acs.langmuir.5b01615
Understanding the Mechanism of Enzyme-Induced Formation of Lyotropic Liquid Crystalline Nanoparticles.
L. Hong (2015)
Semantic Scholar Logo Some data provided by SemanticScholar